Travel expenses of EMA Executive Director
Dear European Medicines Agency,
Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am hereby requesting access to the travel expenses of EMA's Executive Director, for the period 1 January 2016 to 31 December 2016 inclusive.
I am looking for documents that contain, for each of the trips, the following information:
- Place of origin and destination, and the amount spent on travel or transportation;
- Exact dates and duration of the trip;
- Amount spent on accommodation;
- Amount spent on subsistence;
- Other information, such as possible miscellaneous costs.
If the travel was by air taxi and a team of people were travelling, please also provide documents with details on the other travellers (at a minimum, names and job titles).
With respect to personal information contained in any documents that you might have, I note that the only information being sought here is the name and surname of EMA's Executive Director, something which is already in the public domain. This request does not seek access to any other personal information such as bank account details. Nor am I requesting data such as the office addresses, signatures or telephone numbers of EMA staff members.
I remain at your disposition to answer any questions or clarifications you might have related to this request.
Thank you in advance.
Yours faithfully,
Luisa Izuzquiza
Access Info Europe
Dear Sir/Madam,
Thank you for contacting the European Medicines Agency.
Please note that this mailbox is not monitored. If you wish to submit requests for information or access to documents, please use the webform by following the link below:
http://www.ema.europa.eu/ema/index.jsp?c...
For more information on ATD please refer to our guide on access to unpublished documents:
http://www.ema.europa.eu/ema/index.jsp?c...
Best regards,
The European Medicines Agency
Dear Sir/Madam
Re: ASK-37910 Travel expenses of EMA Executive Director received on 16
January 2018
Thank you for submitting your request.
This is an automated response to confirm that we have received your
request; please do not respond to this message.
We endeavour to provide a response to all information enquiries (RFI)
within 2 months according to [1]The European Medicines Agency Code of Good
Administrative Behaviour.
Concerning requests for access to documents (ATD), your enquiry will be
processed according to [2]Regulation (EC) No 1049/2001. .
For more information on ATD please refer to our guide on access to
unpublished documents:
[3]http://www.ema.europa.eu/ema/index.jsp?c...
This automated response is not an acknowledgement of receipt or
registration for the purpose of the ATD process. Such
acknowledgment/registration will be issued separately following
validation.
Should you need to contact us, please always use in the title of your
email, the reference number ASK-37910, which has been allocated to your
request.
Kind regards
European Medicines Agency
30 Churchill Place | Canary Wharf | London E14 5EU | United Kingdom
Got a question? Ask EMA at [4]www.ema.europa.eu/contact
This message and any attachment contain information which may be
confidential or otherwise protected from disclosure. It is intended for
the addressee(s) only and should not be relied upon as legal advice unless
it is otherwise stated. If you are not the intended recipient(s) (or
authorised by an addressee who received this message), access to this
e-mail, or any disclosure or copying of its contents, or any action taken
(or not taken) in reliance on it is unauthorised and may be unlawful. If
you have received this e-mail in error, please inform the sender
immediately.
References
Visible links
1. http://www.ema.europa.eu/docs/en_GB/docu...
2. http://www.europarl.europa.eu/RegData/PD...
3. http://www.ema.europa.eu/ema/index.jsp?c...
4. http://www.ema.europa.eu/contact
Re: EMA request reference ASK-37910
Dear Ms Izuzquiza,
Thank you for contacting us on 16 January 2018.
We hereby acknowledge receipt of your application for access to documents,
which was registered on 17 January 2018 under reference number
[1]ASK-37910.
We will deal with your request as soon as possible and in accordance with
the principles and limits established in Regulation (EC) 1049/2001
regarding public access to European Parliament, Council and Commission
documents (the Regulation), as applicable to the EMA pursuant to Article
73 of Regulation (EC) 726/2004.
In accordance with the Regulation, you will receive a reply within 15
working days. The Agency may extend this period by a further 15 working
days in exceptional circumstances in accordance with the Regulation.
Should such an extension be applied by the Agency, you will be informed of
the extension and the related reasons in due course.
Kind regards,
Document Access and Publication Service
Office of the Deputy Executive Director
European Medicines Agency
30 Churchill Place | Canary Wharf | London E14 5EU | United Kingdom
European Medicines Agency
30 Churchill Place | Canary Wharf | London E14 5EU | United Kingdom
Got a question? Ask EMA at [2]www.ema.europa.eu/contact
This message and any attachment contain information which may be
confidential or otherwise protected from disclosure. It is intended for
the addressee(s) only and should not be relied upon as legal advice unless
it is otherwise stated. If you are not the intended recipient(s) (or
authorised by an addressee who received this message), access to this
e-mail, or any disclosure or copying of its contents, or any action taken
(or not taken) in reliance on it is unauthorised and may be unlawful. If
you have received this e-mail in error, please inform the sender
immediately.
Re: EMA request reference ASK-37910
Dear Ms Izuzquiza,
we have been trying to send you the reply to your request for documents by
Eudralink (a safe electronic correspondence system), but it appears that
asktheeu.org e-mail addresses are not supported.
We would be grateful if you could send us an alternative e-mail address to
which we can send the response.
Please use the webform available in our webpage and quote the reference
number ([1]ASK-37910) in your response.
With kind regards,
Document Access and Publication
Office of the Deputy Executive Director
European Medicines Agency
30 Churchill Place | Canary Wharf | London E14 5EU | United Kingdom
Got a question? Ask EMA at [2]www.ema.europa.eu/contact
This message and any attachment contain information which may be
confidential or otherwise protected from disclosure. It is intended for
the addressee(s) only and should not be relied upon as legal advice unless
it is otherwise stated. If you are not the intended recipient(s) (or
authorised by an addressee who received this message), access to this
e-mail, or any disclosure or copying of its contents, or any action taken
(or not taken) in reliance on it is unauthorised and may be unlawful. If
you have received this e-mail in error, please inform the sender
immediately.
[Subject only] FW: EudraLink - Travel expenses of the Agency’s Executive Director - ASK-37910 – Release letter to the requester